Bolt Biotherapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:BOLT) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -57.07 M-76.5 M-69.53 M-61.29 M-39.85 M -34.51 M Cash from investing activities -232.2 M57.86 M71.04 M57.58 M44.3 M 37.67 M Cash from financing activities 311.11 M503 K253 K108 K19 K 25 K Free cash flow -57.07 M-76.5 M-69.53 M-61.29 M-39.92 M -34.51 M

News

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

Bolt Biotherapeutics CEO Quinn buys shares worth $686

Nemec, Bolt Biotherapeutics SVP, acquired shares worth $686

Bolt Biotherapeutics stock initiated with Buy rating at H.C. Wainwright

Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Mr. Cooper Gr (NASDAQ:COOP), Bolt Biotherapeutics (NASDAQ:BOLT)

Bolt Biotherapeutics delays clinical data, cuts workforce by half

Bolt Biotherapeutics stock falls after clinical data delay to 2026

Bolt Biotherapeutics stock price target cut to $6 from $20 at Leerink Partners

Bolt earnings missed by $4.15, revenue topped estimates